VEGFA and cancer: These reports suggest that anti-VEGF therapy can be the best option for combination therapy with immune checkpoint inhibitors for non-responsive cancer patients due to the lack of immune cells in the tumors, which are so-called ‘cold tumors’ or ‘non-inflamed tumors’.